Application of 3,3'-diindolylmethane and 3,3'-diindolylmethane derivatives in preparation of drugs for treating liver diseases
A technology of diindolylmethane and derivatives, applied in the field of biomedicine
Active Publication Date: 2013-10-23
宁国市吴越医药科技有限公司
View PDF2 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Although 3,3'-diindolylmethane has been reported in the literature that it can protect the body from free radical damage, there is no report on its use in the treatment of liver fibrosis and related hepatitis and cirrhosis
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 4
[0078] As shown in Table 3, intraperitoneal injection of aqueous solution injection preparations of I3C and DIM and its derivative compounds can also reduce the degree of hepatitis attack in mice.
[0079] Table 4 Determination of alanine aminotransferase and aspartate aminotransferase activity in serum
[0080]
[0081]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
This invention relates to biopharmaceutical technology, specifically to the application of 3,3'-Diindolylmethane, indole-3-carbinol, and derivatives thereof in the preparation of drugs for treating such hepatic diseases as viral hepatitis, alcoholic hepatitis, drug-induced hepatitis, fatty liver, hepatic fibrosis and hepatic cirrhosis. The said indole-3-carbinol, diindolylmethane and derivatives thereof can effectively protect the human body from the damage resulting from ROS by inhibiting ROS-induced activation of hepatic stellate cells and correlated expression of collagen, which consequently ameliorates degree of hepatic fibrosis. Therefore they can be used in treatment of diseases related to hepatic fibrosis. As is verified in the animal models of hepatic fibrosis, the said indole-3-carbinol, diindolylmethane and derivatives thereof present excellent therapeutic effect and positive application prospect.
Description
1. Technical field [0001] The invention belongs to the technical field of biomedicine, in particular to 3,3'-diindolylmethane (DIM) and its precursor compound indole-3-carbinol (I3C) and their derivative compounds in the preparation and treatment of liver fibrosis and hepatitis , a drug for cirrhosis-associated liver disease. 2. Background technology [0002] Liver fibrosis refers to the excessive deposition of diffuse extracellular matrix (especially collagen) in the liver. It is not an independent disease. Many chronic liver diseases can cause liver fibrosis. The etiology can be roughly divided into infectious (chronic B, C and D viral hepatitis, schistosomiasis, etc.), congenital metabolic defects ( Hepatolenticular degeneration, hemochromatosis, α1-antitrypsin deficiency, etc.), chemical metabolic defects (chronic alcoholic liver disease, chronic drug-induced liver disease) and autoimmune hepatitis, primary biliary cirrhosis and primary Sclerosing cholangitis, etc. It...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/404A61P1/16A61P31/12
CPCA61K31/404A61P1/16A61P31/12
Inventor 张峻峰董磊黄振张正平
Owner 宁国市吴越医药科技有限公司
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com